Saturday, 06 June 2020


Dr. Reddy's launches Melphalan Hydrochloride for Injection in the U.S. Market

27 December 2017 | News

According to IMS Health data, The Alkeran® brand and generic had U.S. sales of approximately $107 million MAT for the most recent twelve months ending in October 2017

Dr. Reddy’s Laboratories Ltd has announced that it has launched Melphalan Hydrochloride for Injection which is a therapeutic equivalent generic version of Alkeran® (melphalan hydrochloride) for Injection in the United States market approved by the U.S. Food and Drug Administration (USFDA).

According to IMS Health data, The Alkeran® brand and generic had U.S. sales of approximately $107 million MAT for the most recent twelve months ending in October 2017.

Dr. Reddy’s Melphalan Hydrochloride for Injection is available in a carton containing one single dose clear glass vial of freeze-dried melphalan hydrochloride equivalent to 50 mg melphalan and one 10 mL clear glass vial of sterile diluent.


Sign up for the editor pick and get articles like this delivered right to your inbox.

Editors Pick
+Country Code-Phone Number(xxx-xxxxxxx)


Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account